Ajjan Ramzi A
LIGHT Laboratories, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds , Leeds, United Kingdom .
Diabetes Technol Ther. 2017 May;19(S2):S27-S36. doi: 10.1089/dia.2017.0021.
Controlling glycemia in diabetes remains key to prevent complications in this condition. However, glucose levels can undergo large fluctuations secondary to daily activities, consequently creating management difficulties. The current review summarizes the basics of glucose management in diabetes by addressing the main glycemic parameters. The advantages and limitation of HbA1c, the gold standard measure of glucose control, are discussed together with the clinical importance of hypoglycemia and glycemic variability. The review subsequently moves focus to glucose monitoring techniques in diabetes, assessing advantages and limitations. Monitoring glucose levels is crucial for effective and safe adjustment of hypoglycemic therapy, particularly in insulin users. Self-monitoring of blood glucose (SMBG), based on capillary glucose testing, remains one of the most widely used methods to monitor glucose levels, given the relative accuracy, familiarity, and manageable costs. However, patient inconvenience and the sporadic nature of SMBG limit clinical effectiveness of this approach. In contrast, continuous glucose monitoring (CGM) provides a more comprehensive picture of glucose levels, but these systems are expensive and require constant calibration which, together with concerns over accuracy of earlier devices, restrict CGM use to special groups of patients. The newer flash continuous glucose monitoring (FCGM) system, which is more affordable than conventional CGM devices and does not require calibration, offers an alternative glucose monitoring strategy that comprehensively analyzes glucose profile while sparing patients the inconvenience of capillary glucose testing for therapy adjustment or CGM calibration. The fast development of new CGM devices will gradually displace SMBG as the main glucose testing method. Avoiding the inconvenience of SMBG and optimizing glycemia through alternative glucose testing strategies will help to reduce the risk of complications and improve quality of life in patients with diabetes.
控制糖尿病患者的血糖水平仍然是预防该疾病并发症的关键。然而,由于日常活动,血糖水平可能会出现大幅波动,从而带来管理上的困难。本综述通过阐述主要的血糖参数,总结了糖尿病血糖管理的基础知识。讨论了糖化血红蛋白(HbA1c)作为血糖控制的金标准测量指标的优点和局限性,以及低血糖和血糖变异性的临床重要性。随后,综述将重点转向糖尿病的血糖监测技术,评估其优缺点。监测血糖水平对于有效且安全地调整降糖治疗至关重要,尤其是在使用胰岛素的患者中。基于毛细血管血糖检测的自我血糖监测(SMBG),鉴于其相对准确性、普及性和可承受的成本,仍然是监测血糖水平最广泛使用的方法之一。然而,患者的不便以及SMBG的零星性限制了这种方法的临床效果。相比之下,持续葡萄糖监测(CGM)能提供更全面的血糖水平情况,但这些系统价格昂贵且需要持续校准,再加上对早期设备准确性的担忧,使得CGM仅局限于特定患者群体使用。更新的闪光持续葡萄糖监测(FCGM)系统比传统CGM设备更经济实惠且无需校准,提供了一种替代的血糖监测策略,能全面分析血糖情况,同时避免了患者为调整治疗或校准CGM而进行毛细血管血糖检测的不便。新型CGM设备的快速发展将逐渐取代SMBG成为主要的血糖检测方法。避免SMBG带来的不便,并通过替代血糖检测策略优化血糖水平,将有助于降低糖尿病患者并发症的风险并提高其生活质量。